Hepion Pharmaceuticals appoints Danina Fisher and Gary S. Stetz, II to board

Hepion Pharmaceuticals, Inc.

Danina Fisher and Gary S. Stetz, II appointed as directors effective July 1, 2026.
Gary S. Stetz, II is the son of Gary Stetz, the Interim CEO.
No arrangements or understandings with any other person regarding their selection as directors.
No family relationships exist between the new directors except the father-son relationship noted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.